Bionovis Brasil
São Paulo, Brazil· Est.
Brazilian biotech delivering high‑complexity biologics and biosimilars to expand patient access across therapeutic areas.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Brazilian biotech delivering high‑complexity biologics and biosimilars to expand patient access across therapeutic areas.
HematologyImmunologyOncologyOphthalmologyGeneral Diseases
Technology Platform
Advanced bioprocessing platform for high‑complexity protein therapeutics, integrating proprietary cell‑culture, purification, and formulation technologies to produce biologics and biosimilars at commercial scale.
Opportunities
Expanding biosimilar adoption in Brazil’s public health system and leveraging partnerships to enter other Latin American markets.
Risk Factors
Regulatory changes, intense competition from multinational biosimilar producers, and the technical challenges of scaling complex biologic manufacturing.
Competitive Landscape
Competes with regional biosimilar firms such as Eurofarma and Biolab, as well as global players like Sandoz and Biocon, differentiating through local manufacturing capacity and strategic technology transfers.